• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Device Problems Failure to Advance (2524); Material Deformation (2976)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/07/2019
Event Type  Injury  
Manufacturer Narrative
Age at time of event: 18 years or older.
 
Event Description
It was reported that the stent became deformed during deployment.A 7x120x130 eluvia drug-eluting vascular stent system was selected for use for a stenting procedure in the superficial femoral artery (sfa) location.During the procedure the stent did not deploy correctly, elongated and malformed.Physician crushed the stent with a balloon and putted a new stent in the patient to complete the procedure.There were no patient complications.
 
Event Description
It was reported that the stent became deformed during deployment.A 7x120x130 eluvia drug-eluting vascular stent system was selected for use for a stenting procedure in the superficial femoral artery (sfa) location.During the procedure the stent did not deploy correctly, elongated and malformed.Physician crushed the stent with a balloon and putted a new stent in the patient to complete the procedure.There were no patient complications.It was corrected that the device was selected for use within the femoral artery.The stent did not deploy correctly as it elongated and was not uniform during deployment.A balloon was used to 'crush' the stent and a new stent was placed.There were no patient complications.
 
Manufacturer Narrative
Age at time of event: 18 years or older.Adverse event/product problem was corrected from product problem to adverse event and product problem.Describe event or problem was updated for clarity.Type of reportable event was corrected from malfunction to serious injury.Device codes were corrected from 2524 and 2976 to 2976.
 
Event Description
It was reported that the stent became deformed during deployment.A 7x120x130 eluvia drug-eluting vascular stent system was selected for use for a stenting procedure in the superficial femoral artery (sfa) location.During the procedure the stent did not deploy correctly, elongated and malformed.Physician crushed the stent with a balloon and putted a new stent in the patient to complete the procedure.There were no patient complications.It was corrected that the device was selected for use within the femoral artery.The stent did not deploy correctly as it elongated and was not uniform during deployment.A balloon was used to 'crush' the stent and a new stent was placed.There were no patient complications.
 
Manufacturer Narrative
A2: age at time of event: 18 years or older.Device evaluated by manufacturer: the returned product consisted of an eluvia self-expanding stent system with a 0.014 guidewire.The returned guidewire has multiple kinks along it.The outer sheath, tip, inner sheath and the remainder of the device were checked for damage.Visual examination revealed that the inner liner is separated 23.9cm from the tip.The distal end of the separation is stretched and has multiple kinks.The inner liner is also separated 6.1cm from the proximal end of the clip.The inner liner is stretched at the clip.The middle sheath is separated from the retainer on the pull rack.There is buckling to the outer sheath at the nosecone, 43.9cm, 58.1cm, and 58.6cm from the nosecone.The thumbwheel is missing and did not return for product analysis.Microscopic examination revealed that the tip is damaged.Inspection of the remainder of the device, revealed no other damage or irregularities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9161733
MDR Text Key161736456
Report Number2134265-2019-12076
Device Sequence Number1
Product Code NIU
UDI-Device Identifier08714729876731
UDI-Public08714729876731
Combination Product (y/n)N
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 10/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/01/2020
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0023156710
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/03/2019
Initial Date Manufacturer Received 09/17/2019
Initial Date FDA Received10/07/2019
Supplement Dates Manufacturer Received09/17/2019
10/14/2019
Supplement Dates FDA Received10/07/2019
10/30/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-